Information for US Customers: Our dedicated website, sudoscan.us, is currently unavailable. For assistance, please feel free to contact us via email at admin@sudoscan.com or by phone at +18584502800.
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Events
Sudoscan at the SFNP days 21-22 of January 2022 [...]
News
Press release: Withings acquires Impeto Medical Impeto Medical is a [...]
SUDOSCAN at NEURODIAB 2021: Symposium and five oral communications Impeto [...]
Successful Webinar: Management of autonomic dysfunction: challenges & role of [...]
Δ
May 6, 2025